0001127602-21-003237.txt : 20210201 0001127602-21-003237.hdr.sgml : 20210201 20210201163814 ACCESSION NUMBER: 0001127602-21-003237 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210128 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nicholson Nur CENTRAL INDEX KEY: 0001827317 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 21577221 MAIL ADDRESS: STREET 1: APELLIS PHARMACEUTICALS, INC. STREET 2: 100 5TH AVENUE, 3RD FLOOR CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-01-28 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001827317 Nicholson Nur C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Technical Officer Common Stock 2021-01-28 4 A 0 7500 0 A 7500 D Common Stock 2021-01-28 4 A 0 1875 0 A 9375 D Stock Option (Right to Buy) 44.90 2021-01-28 4 A 0 45000 0 A 2031-01-27 Common Stock 45000 45000 D Stock Option (Right to Buy) 44.90 2021-01-28 4 A 0 11250 0 A 2031-01-27 Common Stock 11250 11250 D This Restricted Stock Units grant will vest 25% annually over four years from grant date, subject to continued service. This Performance Unit grant will vest 25% annually over four years from grant date, subject to the satisfaction of a specified performance condition and continued service. This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service. This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to the satisfaction of a specified performance condition and continued service. /s/ David Watson, attorney-in-fact for Nur Nicholson 2021-01-29